Global, regional, and national burden of other musculoskeletal disorders, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

2023· article· en· 376 citations· W4387890132 sur OpenAlex· 10.1016/s2665-9913(23)00232-1

Pourquoi ce travail est-il dans la base ?

Une base qui oublie comment elle a trouvé un travail ne peut pas être vérifiée. Voici les voies qui ont admis celui-ci.

Organisme subventionnaire canadienUn organisme canadien l'a financé. Le travail peut ne porter aucune affiliation canadienne.

Aucune affiliation canadienne. Une base fondée sur la seule affiliation (le devis habituel) n'aurait jamais vu ce travail. C'est l'un des travaux qui justifient l'inversion de la base.

Scores machine (provisoires)

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Tête enseignante Opus0,017

Tête enseignante GPT0,323

Écart entre enseignants: 0,307 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validation: score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Résumé

Background: Musculoskeletal disorders include more than 150 different conditions affecting joints, muscles, bones, ligaments, tendons, and the spine. To capture all health loss from death and disability due to musculoskeletal disorders, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) includes a residual musculoskeletal category for conditions other than osteoarthritis, rheumatoid arthritis, gout, low back pain, and neck pain. This category is called other musculoskeletal disorders and includes, for example, systemic lupus erythematosus and spondylopathies. We provide updated estimates of the prevalence, mortality, and disability attributable to other musculoskeletal disorders and forecasted prevalence to 2050. Methods: Prevalence of other musculoskeletal disorders was estimated in 204 countries and territories from 1990 to 2020 using data from 68 sources across 23 countries from which subtraction of cases of rheumatoid arthritis, osteoarthritis, low back pain, neck pain, and gout from the total number of cases of musculoskeletal disorders was possible. Data were analysed with Bayesian meta-regression models to estimate prevalence by year, age, sex, and location. Years lived with disability (YLDs) were estimated from prevalence and disability weights. Mortality attributed to other musculoskeletal disorders was estimated using vital registration data. Prevalence was forecast to 2050 by regressing prevalence estimates from 1990 to 2020 with Socio-demographic Index as a predictor, then multiplying by population forecasts. Findings: Globally, 494 million (95% uncertainty interval 431-564) people had other musculoskeletal disorders in 2020, an increase of 123·4% (116·9-129·3) in total cases from 221 million (192-253) in 1990. Cases of other musculoskeletal disorders are projected to increase by 115% (107-124) from 2020 to 2050, to an estimated 1060 million (95% UI 964-1170) prevalent cases in 2050; most regions were projected to have at least a 50% increase in cases between 2020 and 2050. The global age-standardised prevalence of other musculoskeletal disorders was 47·4% (44·9-49·4) higher in females than in males and increased with age to a peak at 65-69 years in male and female sexes. In 2020, other musculoskeletal disorders was the sixth ranked cause of YLDs globally (42·7 million [29·4-60·0]) and was associated with 83 100 deaths (73 600-91 600). Interpretation: Other musculoskeletal disorders were responsible for a large number of global YLDs in 2020. Until individual conditions and risk factors are more explicitly quantified, policy responses to this burden remain a challenge. Temporal trends and geographical differences in estimates of non-fatal disease burden should not be overinterpreted as they are based on sparse, low-quality data. Funding: Bill & Melinda Gates Foundation.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

La notice

Revue: The Lancet Rheumatology
Thématique: Musculoskeletal Disorders and Rehabilitation
Domaine: Medicine
Établissements canadiens: —
Organismes subventionnaires: Division of Human Resource DevelopmentFaculty of Medicine and Health, University of SydneyYonsei University College of MedicineRussian Academy of SciencesNational Health and Medical Research CouncilMedical Research CouncilDepartment of Anthropology, McMaster UniversityUniversity of Health and Allied SciencesPirogov Russian National Research Medical UniversityRajshahi UniversityMenzies Institute for Medical ResearchMadda Walabu UniversityRede de Química e TecnologiaNational Center of Neurology and PsychiatryUniversity of Social Welfare and Rehabilitation SciencesUniversity of PeradeniyaSecretaria Nacional de Ciencia y TecnologíaXiamen UniversityBahir Dar UniversityUniversidade de São PauloPanjab UniversityShiraz UniversityPublic Health Foundation of IndiaRoyal College of Surgeons in IrelandMashhad University of Medical SciencesNaresuan UniversityScience and Technology Development FundHong Kong Polytechnic UniversityDirectorate for Biological SciencesMansoura UniversityKing Abdulaziz UniversityTampereen YliopistoSt. George's, University of LondonMinistero della SaluteConselho Nacional de Desenvolvimento Científico e TecnológicoIslamic Azad UniversityKyung Hee UniversityUniversity of Southern CaliforniaYonsei UniversityShiraz University of Medical SciencesUniversity Grants CommitteeAcademy of Scientific Research and TechnologyMonash UniversityIndian Council of Medical ResearchUniversity of California, IrvineUniversity of LeedsNational Institute for Health and Care ResearchHøgskulen på VestlandetSaveetha Dental CollegeUniversity of TasmaniaBill and Melinda Gates FoundationZahedan University of Medical SciencesCurtin University of TechnologyUniversidade Federal de Santa CatarinaUniversity of TorontoMacquarie UniversityKasturba Medical College, ManipalHealth Research Council of New ZealandUniversiteit MaastrichtUniversity of New South WalesYale UniversityU.S. Department of Veterans AffairsBabol University of Medical SciencesUniversity of GlasgowTehran University of Medical Sciences and Health ServicesLaboratório Associado para a Química VerdeUniversitetet i BergenUniversity of South CarolinaShaqra UniversityIran University of Medical SciencesFondation de la recherche en santé du Nouveau-BrunswickUniversity of OtagoBritish Heart FoundationKhalifa University of Science, Technology and ResearchInternational Association for the Study of PainCase Western Reserve UniversityKing Abdulaziz City for Science and TechnologyCleveland Clinic FoundationKaiser Permanente
Mots-clés: Burden of diseaseDisease burdenMedicineDiseaseEnvironmental healthPathology
Résumé présent dans OpenAlex: oui
API: /api/v1/works/W4387890132